Treatment of multiple myeloma.
作者信息
Singhal Seema
出版信息
BMJ. 2003 Sep 13;327(7415):575-6. doi: 10.1136/bmj.327.7415.575.
Abstract
摘要
相似文献
1
Treatment of multiple myeloma.
BMJ. 2003 Sep 13;327(7415):575-6. doi: 10.1136/bmj.327.7415.575.
2
Tandem bone marrow transplantation in multiple myeloma.
N Engl J Med. 2004 Apr 1;350(14):1466-7; author reply 1466-7.
3
The role of transplant in multiple myeloma.
Clin Adv Hematol Oncol. 2005 Aug;3(8):604-6.
4
5
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.
Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):e59-63. doi: 10.1016/j.clml.2013.11.007. Epub 2013 Nov 15.
6
[IgD myeloma].
Ryoikibetsu Shokogun Shirizu. 1998(22 Pt 3):408-10.
7
[Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
Vnitr Lek. 1997 Nov;43(11):756-8.
8
Multiple myeloma.
Hematol Oncol Clin North Am. 2014 Dec;28(6):1113-29. doi: 10.1016/j.hoc.2014.08.010. Epub 2014 Sep 30.
9
Diagnosis and management of multiple myeloma.
Br J Haematol. 2001 Dec;115(3):522-40. doi: 10.1046/j.1365-2141.2001.03206.x.
10
[High-dose melphalan in patients with multiple myeloma].
Bull Cancer. 1999 Mar;86(3):283-8.
本文引用的文献
1
A phase 2 study of bortezomib in relapsed, refractory myeloma.
N Engl J Med. 2003 Jun 26;348(26):2609-17. doi: 10.1056/NEJMoa030288.
2
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.
N Engl J Med. 2003 May 8;348(19):1875-83. doi: 10.1056/NEJMoa022340.
3
Novel therapies in multiple myeloma.
Int J Hematol. 2003 Apr;77(3):226-31. doi: 10.1007/BF02983778.
4
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myeloma.
Bone Marrow Transplant. 2002 Nov;30(10):673-9. doi: 10.1038/sj.bmt.1703717.
5
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.
Blood. 2002 Feb 1;99(3):731-5. doi: 10.1182/blood.v99.3.731.
6
Antitumor activity of thalidomide in refractory multiple myeloma.
N Engl J Med. 1999 Nov 18;341(21):1565-71. doi: 10.1056/NEJM199911183412102.
7
Total therapy with tandem transplants for newly diagnosed multiple myeloma.
Blood. 1999 Jan 1;93(1):55-65.
8
Graft-versus-myeloma.
Bone Marrow Transplant. 1998 Nov;22(9):835-43. doi: 10.1038/sj.bmt.1701459.
9
10
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.
N Engl J Med. 1996 Jul 11;335(2):91-7. doi: 10.1056/NEJM199607113350204.
Zotero 插件